Skip to main content
. 2022 Aug 24;11(17):e022574. doi: 10.1161/JAHA.121.022574

Table 1.

Primary Antibodies

Antibody Company Catalog no. Titer for WB Titer for IHC
Angiotensin II Sigma A9525 1:350
AT1 Santa Cruz sc‐515 884 1:500 1:100
AT2 Abcam Ab92445 1;1000 1:100
Collagen I Santa Cruz sc‐59 772 1:50
GAPDH Cell Signaling technology 5014 1:1000
ICAM1 Santa Cruz Biotechnology Sc‐8439 1:50
MCP1 R&D Systems AF479 1:200
MFG‐E8 R&D Systems AF2805 1:1000
MMP2 R&D Systems AF1488 1:500
MT1‐MMP Thermo Fisher Scientific PA5‐16514 1:500
NF‐κB p65 Santa Cruz Biotechnology sc‐8008 1:500
p‐NF‐κB p65 Santa Cruz Sc‐33 020 1:500 1:50
PCNA Santa Cruz sc‐9857 1:50
p‐Smad2 Santa Cruz Biotechnology 3108 1:500
Smad2 Santa Cruz Biotechnology 5339 1:1000
TGF‐β1 Santa Cruz Biotechnology sc‐146 1:200
TNF‐α Abcam ab9739 1:1000 1:100
VCAM1 Santa Cruz Biotechnology Sc‐13 160 1:50

AT1 indicates angiotensin II receptor type 1; AT2, angiotensin II receptor type 2; ICAM1, intercellular adhesion molecule 1; IHC immunohistochemistry; MCP1, monocyte chemoattractant protein 1; MMP2, matrix metalloproteinase type 2; MT1MMP, member type I of MMP activator; NF‐κB p65, nuclear factor‐kappa beta p65; p‐NF‐κB p65, phosphorylated nuclear factor‐kappa beta p65; PCNA, proliferating cell nuclear antigen; SMAD2, mother against decapentaplegic homolog 2; p‐SMAD2 phosphorylated mother against decapentaplegic homolog 2; TGF‐β1, transforming growth factor beta 1; TNF‐α tumor necrosis factor alpha; VCAM1, vascular cell adhesion molecule 1; and WB, western blotting.